Developmental stage biopharmaceutical company Parion Sciences recently announced that the National Institutes of Health‘s grants over the next 5…
Articles by Patrícia Silva, PhD
Australian specialist pharmaceutical company Pharmaxis has just announced it has successfully enrolled the first participant in an international Phase 3 clinical trial…
Drug discovery company Proteostasis Therapeutics has completed the recruiting process for its Inaugural Cystic Fibrosis Clinical Advisory Board, a new…
McElhattan, Pennsylvania-based Nutek Disposables is conducting a voluntary product recall on the United States for their baby wipes, due to…
Vertex Pharmaceuticals‘ Ivacaftor (Kalydeco), a breakthrough medication for the treatment of patients suffering from a specific gene mutation…
Advocates and fundraisers for Cystic Fibrosis continue to develop creative, unique ways to increase awareness of the disease throughout…
A novel Cystic Fibrosis testing technology that features next-generation DNA sequencing platforms has been launched by Medical Diagnostic Laboratories, L.L.C. Certified by the Clinical…
Specialty drug discovery company Proteostasis Therapeutics, Inc. has officially welcomed 6 new members to its clinical advisory board, who will…
Governor Tom Corbett Every year, millions of babies in the U.S. undergo newborn screening to detect conditions that may…
The National Institutes of Health (NIH) recently awarded $15.6 million in grants to support research into mucolytic agents discovered by …